STRO
Sutro BiopharmaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
STRO vs peer average
77/100
STRO vs. peer average (A vs. C)
Grade spread
A 3 · B 2 · C 1 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BMEA is the first available peer comparator.
Another loose small-cap biotech peer where valuation is dominated by clinical credibility, cash runway and readout timing rather than current revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
STRO
Sutro Biopharma
BMEA
Biomea Fusion
Grade
A
D
Momentum
84
46
Value
41
41
Sentiment
60
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs BMEA
STRO / BMEA
Grade Position
Above peers
STRO vs. peer average (A vs. C)
77/100
Momentum
84
STROValue
41
STROSentiment
60
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs STRO
BMEA is the first peer returned for this comparison set.